| Literature DB >> 24315464 |
Patricia Peñacoba Toribio1, María Emilia Córica Albani2, Mercedes Mayos Pérez3, Arturo Rodríguez de la Serna2.
Abstract
Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus. We report the case of a patient with non-responding SLS (neither to glucocorticoids nor immunosupresors), who showed remarkable improvement after the onset of treatment with rituximab. Although there is a little evidence, treatment with rituximab could be proposed in SLS when classical treatment fails.Entities:
Keywords: Glucocorticoides; Glucocorticoids; Lupus eritematoso sistémico; Rituximab; Shrinking lung syndrome; Systemic lupus erythematosus; Síndrome del pulmón encogido
Mesh：
Substances：
Year: 2013 PMID： 24315464 DOI： 10.1016/j.reuma.2013.09.003
Source DB: PubMed Journal: Reumatol Clin ISSN： 1699-258X